» Articles » PMID: 2341198

Glucocorticoid-induced Appearance of the Macrophage Subtype RM 3/1 in Peripheral Blood of Man

Overview
Publisher Karger
Date 1990 Jan 1
PMID 2341198
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of intravenous administration of the glucocorticoid prednylidene on the macrophage subtype RM 3/1 in the peripheral blood of man was studied. Injection of 60 mg steroid resulted in an increase in the proportion of RM 3/1 positive monocytes 12 h after application from the basic level to about 80%. After 24 h the number of RM 3/1 positive cells decreased but remained elevated over the basis rate for a period of at least 15 days. Similar results were obtained after administration of 30 or 6 mg prednylidene even if the peak value occurred with a delay of 12 h after 6 mg. A dose- and time-dependent induction of the RM 3/1 positive subtype could also be demonstrated in vitro by the addition of prednylidene or dexamethasone to cultured purified human monocytes/macrophages. Deoxycortone or indomethacin had no effects. These results suggest that glucocorticoids exert their influence on cells of the mononuclear phagocytic lineage by inducing a distinct monocyte/macrophage subpopulation which seems to be associated with anti-inflammatory functions.

Citing Articles

The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology.

Plevriti A, Lamprou M, Mourkogianni E, Skoulas N, Giannakopoulou M, Sajib M Cells. 2024; 13(20.

PMID: 39451197 PMC: 11506427. DOI: 10.3390/cells13201679.


CD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage.

Xie W, Yu H, Zhang Y, Liu Q, Meng H Neural Regen Res. 2016; 11(7):1122-7.

PMID: 27630696 PMC: 4994455. DOI: 10.4103/1673-5374.187047.


Immunohistochemical expression of MPO, CD163 and VEGF in inflammatory cells in acute respiratory distress syndrome: a case report.

Maretta M, Toth S, Jonecova Z, Kruzliak P, Kubatka P, Pingorova S Int J Clin Exp Pathol. 2014; 7(7):4539-44.

PMID: 25120850 PMC: 4129085.


Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.

Pey P, Pearce R, Kalaitzakis M, Griffin W, Gentleman S Acta Neuropathol Commun. 2014; 2:21.

PMID: 24528486 PMC: 3940003. DOI: 10.1186/2051-5960-2-21.


The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging.

Thomsen J, Etzerodt A, Svendsen P, Moestrup S Oxid Med Cell Longev. 2013; 2013:523652.

PMID: 23781295 PMC: 3678498. DOI: 10.1155/2013/523652.